WO2008017346A3 - Ascorbinsäurederivate, verwendung zur funktionalisierung von matrices - Google Patents

Ascorbinsäurederivate, verwendung zur funktionalisierung von matrices Download PDF

Info

Publication number
WO2008017346A3
WO2008017346A3 PCT/EP2007/005672 EP2007005672W WO2008017346A3 WO 2008017346 A3 WO2008017346 A3 WO 2008017346A3 EP 2007005672 W EP2007005672 W EP 2007005672W WO 2008017346 A3 WO2008017346 A3 WO 2008017346A3
Authority
WO
WIPO (PCT)
Prior art keywords
ascorbic acid
functionalization
matrices
acid derivatives
processes
Prior art date
Application number
PCT/EP2007/005672
Other languages
English (en)
French (fr)
Other versions
WO2008017346A2 (de
Inventor
Thomas Rudolph
Philipp Buehle
Herwig Buchholz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Priority to EP07785853A priority Critical patent/EP2049075A2/de
Priority to CN2007800298856A priority patent/CN101686925B/zh
Priority to JP2009523160A priority patent/JP5470037B2/ja
Priority to US12/377,008 priority patent/US9023889B2/en
Publication of WO2008017346A2 publication Critical patent/WO2008017346A2/de
Publication of WO2008017346A3 publication Critical patent/WO2008017346A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Gegenstand der Erfindung ist die Verwendung von mindestens einem Ascorbinsäurederivat zur Funktionalisierung von Matrices, sowie spezieller Ascorbinsäurederivate und Verfahren zu ihrer Herstellung.
PCT/EP2007/005672 2006-08-11 2007-06-27 Verwendung von ascorbinsäurederivaten zur funktionalisierung von matrices WO2008017346A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP07785853A EP2049075A2 (de) 2006-08-11 2007-06-27 Verwendung von ascorbinsäurederivaten zur funktionalisierung von matrices
CN2007800298856A CN101686925B (zh) 2006-08-11 2007-06-27 抗坏血酸衍生物用于官能化基质的用途
JP2009523160A JP5470037B2 (ja) 2006-08-11 2007-06-27 マトリックスの官能化のためのアスコルビン酸誘導体の使用
US12/377,008 US9023889B2 (en) 2006-08-11 2007-06-27 Use of ascorbic acid derivatives for the functionalization of matrices

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006037724.9 2006-08-11
DE102006037724A DE102006037724A1 (de) 2006-08-11 2006-08-11 Verwendung von Ascorbinsäurederivaten zur Funktionalisierung von Matrices

Publications (2)

Publication Number Publication Date
WO2008017346A2 WO2008017346A2 (de) 2008-02-14
WO2008017346A3 true WO2008017346A3 (de) 2010-01-07

Family

ID=38805782

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/005672 WO2008017346A2 (de) 2006-08-11 2007-06-27 Verwendung von ascorbinsäurederivaten zur funktionalisierung von matrices

Country Status (6)

Country Link
US (1) US9023889B2 (de)
EP (1) EP2049075A2 (de)
JP (1) JP5470037B2 (de)
CN (1) CN101686925B (de)
DE (1) DE102006037724A1 (de)
WO (1) WO2008017346A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007057543A1 (de) 2007-11-29 2009-06-04 Merck Patent Gmbh a-Aminosäurederivate zur Löslichkeitsverbesserung
CN101939310A (zh) * 2008-02-06 2011-01-05 默克专利股份有限公司 基于抗坏血酸衍生物的uvb滤光剂
EP2238121A1 (de) * 2008-02-06 2010-10-13 Merck Patent GmbH Uva filter auf der basis von ascorbinsäurederivaten
DE102008031480A1 (de) * 2008-07-03 2010-01-07 Merck Patent Gmbh Salze enthaltend ein Pyrimidincarbonsäure-Derivat
WO2010060513A2 (de) * 2008-11-26 2010-06-03 Merck Patent Gmbh Verfahren zur photostabilisierung von ascorbinsäurederivaten
JP2012526058A (ja) * 2009-05-08 2012-10-25 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング ケイ皮酸アスコルバート
CN101550119B (zh) * 2009-05-11 2012-05-30 无锡宏瑞生物医药科技有限公司 芳基(乙)丙酸抗坏血酸酯,其制备方法及含有它们的药物
JP2011042648A (ja) * 2009-07-23 2011-03-03 Iwase Cosfa Kk 爪およびその周囲の外観の改善剤組成物
EP2640713B1 (de) 2010-11-19 2014-08-20 Merck Patent GmbH Ascorbinsäurederivate als oxidationsfarbstoffkomponenten
DE102010051725A1 (de) 2010-11-19 2012-05-24 Merck Patent Gmbh Verwendung von Ascorbinsäurederivaten zur Färbung von keratinhaltigen Fasern
FR2967683B1 (fr) * 2010-11-24 2012-11-02 Oreal Nouveaux colorants directs a motif derive de l'acide ascorbique, composition de teinture les comprenant et procede de coloration des matieres keratiniques humaines a partir de ces colorants
CN104837823A (zh) 2012-12-13 2015-08-12 默克专利股份有限公司 作为蛋白质-粘附性活性物质的3-羟基-4-氧代-4h-吡喃或3-羟基-4-氧代-1,4-二氢吡啶衍生物
JP6114643B2 (ja) * 2013-06-25 2017-04-12 日本曹達株式会社 農園芸用組成物
FR3015244A1 (fr) * 2013-12-23 2015-06-26 Oreal Procede de traitement des fibres keratiniques avec un compose d'acide ascorbique
CN110467689A (zh) * 2019-09-09 2019-11-19 山东众山生物科技有限公司 一种透明质酸衍生物及其制备方法
JP2021123535A (ja) * 2020-01-31 2021-08-30 株式会社 資生堂 染毛退色防止用組成物又は染毛用キット
CN115260170B (zh) * 2021-04-30 2024-05-28 禾美生物科技(浙江)有限公司 抗坏血酸多肽衍生物及其制备方法和应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329290A (en) * 1976-07-01 1982-05-11 Sawyer Philip Nicholas Antithrombotic derivatives of ammonium ascorbate
EP0875246A1 (de) * 1997-04-04 1998-11-04 Showa Denko Kabushiki Kaisha Pharmazeutische Zusammensetzung aus Ascorbinsäurederivate zur Behandlung von Krebs
US6132916A (en) * 1996-11-21 2000-10-17 Minolta Co., Ltd. Toner for developing electrostatic latent images
ES2189602A1 (es) * 2000-10-11 2003-07-01 Univ Murcia Procedimiento para la inmovilizacion de un ligando sobre un soporte.
US20030153736A1 (en) * 1999-12-23 2003-08-14 Susan Champion Labelled ascorbic acid derivatives
EP1527777A1 (de) * 2003-10-31 2005-05-04 MERCK PATENT GmbH Zubereitung mit antioxidanten Eigenschaften, die einen Benzoesäureester der Ascorbinsäure enthält
US20050164136A1 (en) * 2004-01-26 2005-07-28 Eastman Kodak Company Ascorbic acid compounds as reducing agents for thermally developable compositions and imaging materials

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2150140A (en) 1937-04-24 1939-03-07 Hoffmann La Roche Derivatives of ascorbic acid having an antiscorbutic action and process for the manufacture of same
US4179445A (en) 1976-05-06 1979-12-18 Kansas State University Research Foundation Method of preparation of 2-phosphate esters of ascorbic acid
US4560703A (en) 1982-09-27 1985-12-24 Fujisawa Pharmaceutical Co., Ltd. Clavulone derivatives, process for preparing the same, and use of said compounds
JPS604127A (ja) 1983-06-21 1985-01-10 Daikin Ind Ltd 抗菌剤
ATE192487T1 (de) 1992-02-13 2000-05-15 Surmodics Inc Immobilisierung eines chemischen spezies in einer vernetzten matrix
FR2715156B1 (fr) 1994-01-20 1996-03-01 Oreal Mono-esters d'acide cinnamique ou de ses dérivés et de vitamine C, leur procédé de préparation et leur utilisation comme anti-oxydants dans des compositions cosmétiques, pharmaceutiques ou alimentaires.
JPH10330261A (ja) * 1997-04-04 1998-12-15 Showa Denko Kk ガン治療用薬剤
DE19750526A1 (de) * 1997-11-14 1999-05-20 Basf Ag Ascorbinsäurederivate enthaltende kosmetische und pharmazeutische Zubereitungen
JP4111856B2 (ja) 2002-04-12 2008-07-02 昭和電工株式会社 安定化されたアスコルビン酸誘導体
US20070167517A1 (en) * 2003-04-21 2007-07-19 Tagra Biotechnologies Ltd. Stabilized derivatives of ascorbic aicd
DE102004039281A1 (de) 2004-08-13 2006-02-23 Merck Patent Gmbh UV Filter
EP2068820A4 (de) * 2006-10-10 2011-03-02 Applechem Inc Neue erdölgele und ihre anwendung

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329290A (en) * 1976-07-01 1982-05-11 Sawyer Philip Nicholas Antithrombotic derivatives of ammonium ascorbate
US6132916A (en) * 1996-11-21 2000-10-17 Minolta Co., Ltd. Toner for developing electrostatic latent images
EP0875246A1 (de) * 1997-04-04 1998-11-04 Showa Denko Kabushiki Kaisha Pharmazeutische Zusammensetzung aus Ascorbinsäurederivate zur Behandlung von Krebs
US20030153736A1 (en) * 1999-12-23 2003-08-14 Susan Champion Labelled ascorbic acid derivatives
ES2189602A1 (es) * 2000-10-11 2003-07-01 Univ Murcia Procedimiento para la inmovilizacion de un ligando sobre un soporte.
EP1527777A1 (de) * 2003-10-31 2005-05-04 MERCK PATENT GmbH Zubereitung mit antioxidanten Eigenschaften, die einen Benzoesäureester der Ascorbinsäure enthält
US20050164136A1 (en) * 2004-01-26 2005-07-28 Eastman Kodak Company Ascorbic acid compounds as reducing agents for thermally developable compositions and imaging materials

Also Published As

Publication number Publication date
JP5470037B2 (ja) 2014-04-16
DE102006037724A1 (de) 2008-02-14
CN101686925B (zh) 2013-04-03
EP2049075A2 (de) 2009-04-22
US20100167936A1 (en) 2010-07-01
WO2008017346A2 (de) 2008-02-14
US9023889B2 (en) 2015-05-05
CN101686925A (zh) 2010-03-31
JP2010505749A (ja) 2010-02-25

Similar Documents

Publication Publication Date Title
WO2008017346A3 (de) Ascorbinsäurederivate, verwendung zur funktionalisierung von matrices
WO2008127364A3 (en) Antiviral compounds and use thereof
WO2008049116A3 (en) Substituted indoles
WO2007086001A3 (en) Novel pyridine derivatives
WO2008115281A3 (en) Compounds for treating viral infections
WO2007021937A3 (en) Unsaturated heterocyclic derivatives
WO2007093627A3 (de) Biozide zusammensetzung
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2010069532A8 (en) Antibodies against human angiopoietin 2
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2007109605A3 (en) Pharmaceutical compositions
WO2007131016A3 (en) Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
WO2007127292A3 (en) Tigeycline crystalline forms and processes for preparation thereof
WO2009071689A3 (de) 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
WO2008027600A3 (en) Imatinib compositions
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2007093365A3 (en) Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
WO2009051460A3 (en) Peptide coupled ascorbic acid derivatives
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2009094457A3 (en) Substituted benzhydrylethers
WO2009002538A3 (en) Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib
WO2009051417A3 (en) Phenanthrene lactam derivatives having anticancer activity and method for the preparation thereof
WO2008073863A3 (en) Preparation and utility of substituted allylamines

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780029885.6

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07785853

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2007785853

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2009523160

Country of ref document: JP

Ref document number: 12377008

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 916/KOLNP/2009

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: RU